Skip to main content
. 2020 Jan 23;28(1):219–226. doi: 10.5606/tgkdc.dergisi.2020.18041

Table 1. Comparisons between non-syndromic and syndromic PMV patients.

Clinical presentation Non-syndromic PMV Syndromic PMV      
  n % n % Test χ2 p
Case number 287 87,0 43 13,0 Chi-square 360,8 <0.001
Gender 0,1 1,000          
Male (n=135) 128 94,8 7 5,2 Chi-square    
Female (n=101) 95 94,1 6 5,9 Chi-square    
Child/adult 26,8 <0.001          
Child (n=166) 145 87,3 21 12,7 Chi-square    
Adult (n=58) 32 55,2 26 44,8 Chi-square    
Asymptomatic (n=26) 25* 26,3 1 8,3 Fisher exact 1,9 0,286
Symptomatic (n=81) 70 73,7 11 91,7 Chi-square 1,9  
Heart failure 38 54,3 1 9,1 Fisher exact 7,8 0,007
Dyspnea/tachypnea 14 20,0 8 72,7 Chi-square 13,4 0,001
Associated cardiac anomaly            
Coarctation of the aorta 82 28,6 33 76,7 Chi-square 38,2 <0.001
Bicuspid aortic valve 63 22,0 30 69,8 Chi-square 68,3 <0.001
Hypoplastic left ventricle 36 12,5 0 0 Fisher exact    
Atrioventricular septal defect 26 9,1 0 0 Fisher exact 4,2 0,034
Subaortic obstruction  25  8.7 12  27,9  Chi-square  13,8  0.001
Tricuspid regurgitation  3 1.0 4 9.3 Fisher exact 12.3 0.007
Anomalous origin of coronary artery 1 0.3 2 4.7 Fisher exact 7.7 0.046
Left superior vena cava 1 0.3 7 16.3 Fisher exact 40.1 <0.001
Supravalvular aortic stenosis 1 0.3 3 7.0 Fisher exact 13.7 0.008
PMV: parachute mitral valve; * One of the asymptomatic patients developed dyspnea later.[41]